Analysis on the Impact of CHS-DRG Payment Method on Hospitalization Expenses of Lung Cancer Patients Undergoing Thoracoscopic Surgery in a Hospital
Objectives To discuss the changes of hospitalization expenses of patients undergoing thoracoscopic surgery for lung cancer before and after CHS-DRG payment method,so as to provide a basis for reasonable control of medical expenses and reduction of patients'disease burden.Methods A total of 3161 cases of patients undergoing thoracoscopic surgery were extracted in a tertiary hospital in Nanjing from January 1st,2021 to December 31st,2021 before CHS-DRG payment method(1779 cases)and from January 1st,2022 to December 31st,2022 after CHS-DRG payment method(1382 cases).The data were imported into the Excel 2017 database,and SPSS 27.0 statistical software was used to perform descriptive and inferential statistical analysis on each group of data before and after the implementation of CHS-DRG payment.Results CHS-DRG payment could reduce the length of stay of patients undergoing thoracoscopic surgery for lung cancer:the average length of stay before CHS-DRG payment was 8.59 days,and the average length of stay after CHS-DRG payment was 7.63 days.The hospitalization expenses of patients undergoing thoracoscopic surgery for lung cancer after CHS-DRG implementation were significantly lower than those before CHS-DRG implementation:the average cost per time decreased by 4 862.29 Yuan(decreased by 7.29％),the cost of surgical materials decreased by 3 422.13 Yuan(decreased by 12.90％),the cost of drugs decreased by 1 659.30 Yuan(decreased by 9.05％),and the cost of inspection decreased by 1 502.67 Yuan(decreased by 13.38％);the operation cost increased by 1 474.77 Yuan(21.96％),and the treatment cost increased by 213.65 Yuan(7.81％).Normal distribution test was performed for each group and t-test was used to analyze each group,and the results showed that the difference was statistically significant.In the proportion of hospitalization expenses,the proportion of surgical materials,medicine and inspection fees decreased by 2.41％,0.52％and 1.11％respectively after CHS-DRG payment.At the same time,the proportion of surgical expenses and treatment expenses was rising by 3.18％and 0.67％respectively.Conclusions After the implementation of CHS-DRG payment,the average cost,surgical material cost,drug cost and inspection cost of patients undergoing thoracoscopic surgery for lung cancer were effectively reduced.The medical cost control had achieved certain results,the medical cost structure had been optimized to a certain extent,and the patient's disease burden had been reduced to a certain extent.At the same time,there was still room for adjustment in optimizing the structure of medical expenses.
Diagnosis Related GroupsLung cancerThoracoscopic surgeryHospitalization expenses
NETL
NSTL
万方数据
